BIOPIX DNA TECHNOLOGY S.A. logo — Diagnostic solutions on the front lines of healthcare, enabl...

BIOPIX DNA TECHNOLOGY S.A.

Diagnostic solutions on the front lines of healthcare, enabling lab-quality testing anytime, anywhere.

Founded 2019 Greece Greece 16 employees Seed Total: $1.45M Biotechnology, Health Care

General Information

Company Name BIOPIX DNA TECHNOLOGY S.A.
Founded Year 2019
Location Greece Greece +2
Employees 16
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when BIOPIX DNA TECHNOLOGY S.A. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BIOPIX DNA TECHNOLOGY S.A.

Biopix DNA Technology, with the slogan "Diagnostic solutions on the front lines of healthcare, enabling lab-quality testing anytime, anywhere," is a certified MedTech Company founded in 2019. The company is compliant with ISO 13485:2016 & 27001:2013 standards and specializes in the design, development, production, storage, and distribution of molecular diagnostic devices and nucleic acid amplification kits for point-of-care applications. Biopix DNA Technology's focus is on healthcare-diagnostics markets, offering instruments and standardized assays for pathogen detection and monitoring in Human (Infectious Diseases and Companion Diagnostics), Food, Plant, Veterinary, and Environmental samples. Their mission is to make BIOPIX-T's diagnostic solutions accessible on the front lines of healthcare, enabling lab-quality testing anytime, anywhere. The company's last investment was a €1.45M Seed Round led by BIOPIX investment on 09 September 2020, with participation from Eleven Ventures and Metavallon VC. Headquartered in Greece, Biopix DNA Technology operates in the Biotechnology and Health Care industries, aiming to revolutionize healthcare diagnostics.

Taxonomy: Molecular Diagnostics, Point of Care, Portable Diagnostic Tools, Accessible Healthcare, Financial Inclusivity, Location Accessibility, Training Levels, Healthcare Innovation, Medical Innovation, Healthcare Access, Diagnostic Equipment, Mobile Healthcare

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round - BIOPIX •••••• 2
Investor Investor
09 Sep 2020

BIOPIX DNA TECHNOLOGY S.A. Alternatives & Competitors

BIOPIX DNA TECHNOLOGY S.A. vs

Our Vision. Our Promise.

14 employees
Medical Devices
BIOPIX DNA TECHNOLOGY S.A. vs

Dedicated to providing tomorrow’s healthcare technology to Canadians, today.

61 employees
Health Care
BIOPIX DNA TECHNOLOGY S.A. vs

We endeavor to provide quality services with cost effectiveness.

311 employees
Health Care, Health and Wellness

FAQ About BIOPIX DNA TECHNOLOGY S.A.

Diagnostic solutions on the front lines of healthcare, enabling lab-quality testing anytime, anywhere.
BIOPIX DNA TECHNOLOGY S.A. was founded in 2019.
BIOPIX DNA TECHNOLOGY S.A. is headquartered in Greece.
BIOPIX DNA TECHNOLOGY S.A. operates in the following industries: Biotechnology, Health Care.
BIOPIX DNA TECHNOLOGY S.A. has approximately 16 employees.
BIOPIX DNA TECHNOLOGY S.A. has completed 1 funding round, raising a total of $1.45M. The latest funding stage is Seed.
Top alternatives and competitors to BIOPIX DNA TECHNOLOGY S.A. include aprimeo diagnostics GmbH & Co. KG, Somagen Diagnostics, Atulaya Healthcare, Lucid Medical Diagnostics, Yoda Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOPIX DNA TECHNOLOGY S.A. and aprimeo diagnostics GmbH & Co. KG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BIOPIX DNA TECHNOLOGY S.A. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy